The Food and Drug Administration (FDA) has approved a new blood test that could help doctors diagnose and treat Alzheimer’s disease faster and more accurately.
According to the FDA, nearly 7 million Americans are living with Alzheimer’s Disease, and this number is projected to rise to nearly 13 million.
The test is for people 55 and older who already have memory issues or signs of the disease. The results would show whether the person’s brain contains amyloid plaque clumps of a toxic protein thought to be a key indicator of Alzheimer’s. Right now, PET scans or spinal taps are the gold standard for detecting these amyloid plaques.
But this new blood test could be less invasive and produce faster results.
Dr. Greg Cooper with the Norton Neuroscience Institute said this test can more quickly identify people that would be eligible for treatments that can slow down the course of this disease, and it is a way that is going to be much more widely available and acceptable to patients.
He said if all goes well, these tests could be available to patients in a matter of months.
Source: WAVE
You must be logged in to post a comment.